REGENERON PHARMACEUTICALS, INC. Current Assets 2009-2026 | REGN
What is current assets?
Current assets are resources expected to be converted to cash or consumed within one year or the normal operating cycle of the business.
What is REGENERON PHARMACEUTICALS, INC.'s current current assets?
REGENERON PHARMACEUTICALS, INC. (REGN) annual current assets for 2025 was $18.02B, a 3.42% decline from 2024. REGENERON PHARMACEUTICALS, INC. current assets for the quarter ending March 31, 2026 was $18.21B.
What was REGENERON PHARMACEUTICALS, INC.'s current assets in 2024?
REGENERON PHARMACEUTICALS, INC. annual current assets for 2024 was $18.66B, a 4.20% decline from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s current assets in 2023?
REGENERON PHARMACEUTICALS, INC. annual current assets for 2023 was $19.48B, a 22.63% increase from 2022.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year current assets CAGR?
REGENERON PHARMACEUTICALS, INC. current assets grew at a compound annual growth rate (CAGR) of 13.01% from FY2020 to FY2025, going from $9.78B to $18.02B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $18.02B | -3.4% | 10-K |
| FY2024 | $18.66B | -4.2% | 10-K |
| FY2023 | $19.48B | +22.6% | 10-K |
| FY2022 | $15.88B | +13.3% | 10-K |
| FY2021 | $14.01B | +43.3% | 10-K |
| FY2020 | $9.78B | +27.2% | 10-K |
| FY2019 | $7.69B | +19.3% | 10-K |
| FY2018 | $6.45B | +48.7% | 10-K |
| FY2017 | $4.33B | +36.3% | 10-K |
| FY2016 | $3.18B | +9.1% | 10-K |
| FY2015 | $2.92B | +39.8% | 10-K |
| FY2014 | $2.08B | +16.0% | 10-K |
| FY2013 | $1.80B | +49.0% | 10-K |
| FY2012 | $1.21B | +81.1% | 10-K |
| FY2011 | $665.8M | +86.2% | 10-K |
| FY2010 | $357.6M | -16.0% | 10-K |
| FY2009 | $425.5M | - | 10-K |